Add Formweb to your mobile device
Search results for:
denosumab
denosumab
Brand names: Prolia, Xgeva
| Form | Strength | ANAN | ASMP | LACH | LALK | LOHH | LOLR | LOWC | SDSD | SESE | SFSF | Formulary Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SOLUTION, SUBCUTANEOUS | 60 mg/mL; 120 mg/1.7 mL | restricted |
Last updated: Feb. 16, 2024
- Black Box Warning: Prolia - Severe Hypocalcemia in Patients with Advanced Kidney Disease
- Restricted: denosumab (Prolia) is restricted to use in the Outpatient setting
- Restricted: denosumab (Xgeva) is restricted to use in the Outpatient setting for prevention of skeletal-related events in oncology patients with bone metastasis from solid tumors who are unable to take bisphosphonates due to renal insufficiency (CrCl <30ml/min)
Chemotherapy Chart